These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 37020547)

  • 41. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
    Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease.
    Luo X; Luo SZ; Xu ZX; Zhou C; Li ZH; Zhou XY; Xu MY
    World J Gastroenterol; 2021 Apr; 27(14):1419-1434. PubMed ID: 33911465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Research progress of extracellular vesicles in hepatic fibrosis].
    Tao CY; Guo JS; Shi YH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):407-410. PubMed ID: 31357753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury.
    Sharma S; Ghufran SM; Das B; Roy B; Ghose S; Biswas S
    Life Sci; 2021 Dec; 287():120119. PubMed ID: 34743004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload.
    Dong Z; Yang X; Qiu T; An Y; Zhang G; Li Q; Jiang L; Yang G; Cao J; Sun X; Liu X; Liu D; Yao X
    Chem Biol Interact; 2022 May; 358():109899. PubMed ID: 35305974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway.
    Wang Y; Wang P; Yu Y; Huang E; Yao Y; Guo D; Peng H; Tian B; Zheng Q; Jia M; Wang J; Wu X; Cheng J; Liu H; Wang QK; Xu C
    Metabolism; 2023 Mar; 140():155380. PubMed ID: 36549436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
    Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
    Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances on liver cell-derived exosomes in liver diseases.
    Jiao Y; Xu P; Shi H; Chen D; Shi H
    J Cell Mol Med; 2021 Jan; 25(1):15-26. PubMed ID: 33247543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
    Hwang S; Yang YM
    Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem Cell-based Therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic Cells.
    Deng Y; Xia B; Chen Z; Wang F; Lv Y; Chen G
    Stem Cell Rev Rep; 2022 Jan; 18(1):77-93. PubMed ID: 34668120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 54. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
    Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
    Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anti-fibrotic role of mast cells in the liver is mediated by HLA-G and interaction with hepatic stellate cells.
    Amiot L; Vu N; Drenou B; Scrofani M; Chalin A; Devisme C; Samson M
    Cytokine; 2019 May; 117():50-58. PubMed ID: 30825834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury.
    Brandon-Warner E; Feilen NA; Culberson CR; Field CO; deLemos AS; Russo MW; Schrum LW
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1430-42. PubMed ID: 27291156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D receptor (VDR) mediates the quiescence of activated hepatic stellate cells (aHSCs) by regulating M2 macrophage exosomal smooth muscle cell-associated protein 5 (SMAP-5).
    Liu X; Wu Y; Li Y; Li K; Hou S; Ding M; Tan J; Zhu Z; Tang Y; Liu Y; Sun Q; Wang C; Zhang C
    J Zhejiang Univ Sci B; 2023 Mar; 24(3):248-261. PubMed ID: 36916000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
    Matsuda M; Tsurusaki S; Miyata N; Saijou E; Okochi H; Miyajima A; Tanaka M
    Hepatology; 2018 Jan; 67(1):296-312. PubMed ID: 28779552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis.
    Huang YJ; Cao J; Lee CY; Wu YM
    Stem Cell Res Ther; 2021 Nov; 12(1):568. PubMed ID: 34772443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.
    Luo N; Li J; Chen Y; Xu Y; Wei Y; Lu J; Dong R
    Drug Deliv; 2021 Dec; 28(1):10-18. PubMed ID: 33336604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.